Ordinary Rebalance | Medical Care Growth Index | Effective Date 3rd August 2023
In the ordinary rebalancing the following index composition will be implemented effective open 03.08.2023:
| ARBUTUS BIOPHARMA CORP |
| ADMA BIOLOGICS INC |
| AGILON HEALTH ORD |
| AMYLYX PHARMACEUTICALS INC |
| ANI PHARMACEUTICALS INC |
| APPLIED DNA SCIENCES INC |
| APELLIS PHARMACEUTICALS INC |
| ARDELYX INC |
| ASSERTIO HOLDINGS INC |
| AXONICS INC |
| CATALYST PHARMACEUTICALS INC |
| DOCGO INC |
| G1 THERAPEUTICS INC |
| HIMS & HERS HEALTH INC |
| HARROW HEALTH INC |
| IMMUNOGEN INC |
| INSPIRE MEDICAL SYSTEMS INC |
| INTRA-CELLULAR THERAPIES INC |
| LINEAGE CELL THERAPEUTICS INC |
| LANTHEUS HOLDINGS INC |
| MACROGENICS INC |
| MIRUM PHARMACEUTICALS INC |
| MANNKIND CORP |
| MERSANA THERAPEUTICS INC |
| OSCAR HEALTH INC |
| PENUMBRA INC |
| PROCEPT BIOROBOTICS ORD |
| REVANCE THERAPEUTICS INC |
| RHYTHM PHARMACEUTICALS INC |
| SAGE THERAPEUTICS INC |
| SEER INC |
| THE BEAUTY HEALTH COMPANY |
| SENSUS HEALTHCARE INC |
| SHOCKWAVE MEDICAL INC |
| TACTILE SYSTEMS TECHNOLOGY INC |
| TG THERAPEUTICS INC |
| TRANSMEDICS GROUP INC |
| 2SEVENTY BIO INC-W/I |
| UROGEN PHARMA LTD |
| XERIS BIOPHARMA HOLDINGS INC |
| Y-MABS THERAPEUTICS INC |
| ZYMEWORKS INC |